 A recent systematic review of four
prospective randomized trials did not demonstrate any
improvement in patency at 12 months with ASA compared
with placebo.240 Nonetheless, antiplatelet therapy may be
warranted in patients undergoing EVT for claudication as
part of an aggressive medical treatment program to prevent
long-term cardiovascular complications such as stroke and
myocardial infarction. In addition, the same review evaluated
the potential effect of using higher